13 Head and Neck - Oropharynx

Head and Neck - Oropharynx

23

THE GEC ESTROHANDBOOKOF BRACHYTHERAPY | Part II Clinical Practice Version 1 - 15/02/2021

15. REFERENCES

and neck cancers. Brachytherapy 2011;10:81–6. https://doi.org/10.1016/j. brachy.2010.03.001. 18. Levendag PC, Teguh DN, Voet P, van der Est H, Noever I, de Kruijf WJM, et al. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship. Radiother Oncol J Eur SocTher Radiol Oncol 2007;85:64–73. https://doi.org/10.1016/j.radonc.2007.07.009. 19. Eisbruch A, Levendag PC, Feng FY, Teguh D, Lyden T, Schmitz PIM, et al. Can IMRT or brachytherapy reduce dysphagia associated with chemoradiotherapy of head and neck cancer? The Michigan and Rotterdam experiences. Int J Radiat Oncol Biol Phys 2007;69:S40-42. https://doi.org/10.1016/j.ijrobp.2007.04.083. 20. Martinez Monge Rafael, Guinot Jose Louis, Haie Meder Christine. General Apects of Head Neck Brachytherapy:GEC ESTROHandbook of Brachytherapy (Second Edition), n.d. 21. Kovács G. Modern head and neck brachytherapy: from radium towards intensity modulated interventional brachytherapy. J Contemp Brachytherapy 2015;6:404–16. https://doi.org/10.5114/jcb.2014.47813. 22. Sturgis EM, Ang KK. The epidemic of HPV-associated oropharyngeal cancer is here: is it time to change our treatment paradigms? J Natl Compr Cancer Netw JNCCN 2011;9:665–73. https://doi.org/10.6004/jnccn.2011.0055. 23. Klussmann JP, Weissenborn SJ, Wieland U, Dries V, Kolligs J, Jungehuelsing M, et al. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer 2001;92:2875–84. https://doi.org/10.1002/1097- 0142(20011201)92:11<2875::aid-cncr10130>3.0.co;2-7. 24. Mazeron J-J, Ardiet J-M, Haie-Méder C, Kovács G, Levendag P, Peiffert D, et al. GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas. Radiother Oncol J Eur Soc Ther Radiol Oncol 2009;91:150–6. https://doi.org/10.1016/j.radonc.2009.01.005. 25. Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3multicentre randomised controlled trial. Lancet Oncol 2011;12:127–36. https://doi.org/10.1016/S1470-2045(10)70290-4. 26. Gupta T, Agarwal J, Jain S, Phurailatpam R, Kannan S, Ghosh-Laskar S, et al. Three-dimensional conformal radiotherapy (3D-CRT) versus intensitymodulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial. Radiother Oncol J Eur Soc Ther Radiol Oncol 2012;104:343–8. https://doi.org/10.1016/j.radonc.2012.07.001. 27. Al-Mamgani A, van Rooij P, Fransen D, Levendag P. Unilateral neck irradiation for well-lateralized oropharyngeal cancer. Radiother Oncol J Eur Soc Ther Radiol Oncol 2013;106:69–73. https://doi.org/10.1016/j.radonc.2012.12.006. 28. Huang SH, Waldron J, Bratman SV, Su J, Kim J, Bayley A, et al. Re-evaluation of Ipsilateral Radiation for T1-T2N0-N2b Tonsil Carcinoma at the Princess Margaret Hospital in the Human Papillomavirus Era, 25 Years Later. Int J Radiat Oncol Biol Phys 2017;98:159–69. https://doi.org/10.1016/j.ijrobp.2017.01.018. 29. GEC-ESTRO. Report 89: Prescribing, Recording and Reporting Brachytherapy for Cancer of the Cervix. J ICRU 2013;13:NP. https://doi.org/10.1093/jicru/ndw042. 30. Mazeron JJ, Van Limbergen E. Oropharynx . The GEC ESTRO Handbook of Brachytherapy. 2002, 275-287. 31. Vikram B, Hilaris BS. A non-looping afterloading technique for interstitial implants of the base of the tongue. Int J Radiat Oncol Biol Phys 1981;7:419–22. 32. Bhalavat RI, Laskar S, Saple M. Technique for interstitial brachytherapy of carcinoma of the tongue. J Brachytherapy Int 1998; 14: 179-183. J Bhrachytherapy Int n.d.;14:179–83. 33. Johansson B, Karlsson L, Reizenstein J, von Beckerath M, Hardell L, Persliden J. Pulsed dose rate brachytherapy as the boost in combination with external beam irradiation in base of tongue cancer. Long-term results from a uniform clinical series. J Contemp Brachytherapy 2011;3:11–7. https://doi.org/10.5114/ jcb.2011.21037. 34. Puthawala AA, Syed AM, Eads DL, Gillin L, Gates TC. Limited external beam and interstitial 192iridium irradiation in the treatment of carcinoma of the base of the tongue: a ten year experience. Int J Radiat Oncol Biol Phys 1988;14:839–48. https://doi.org/10.1016/0360-3016(88)90003-x. 35. Pernot M, Malissard L, Hoffstetter S, Luporsi E, Aletti P, Peiffert D, et al. Influence of tumoural, radiobiological, and general factors on local control and survival of a series of 361 tumours of the velotonsillar area treated by exclusive irradiation (external beam irradiation+brachytherapy or brachytherapy alone). Int J Radiat

1. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol Off J Am Soc Clin Oncol 2011;29:4294–301. https://doi. org/10.1200/JCO.2011.36.4596. 2. O’Sullivan B, Huang SH, Su J, Garden AS, Sturgis EM, Dahlstrom K, et al. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration onOropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. Lancet Oncol 2016;17:440–51. https://doi.org/10.1016/S1470-2045(15)00560-4. 3. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363:24–35. https://doi.org/10.1056/NEJMoa0912217. 4. Amin MB. (ed.). American Joint Committee on Cancer Staging Manual. 8th ed. New York: Springer, 2017. n.d. 5. MurthyV,SwainM,TeniT,PawarS,KalkarP,PatilA,etal.Humanpapillomavirus/ p16 positive head and neck cancer in India: Prevalence, clinical impact, and influence of tobacco use. Indian J Cancer 2016;53:387–93. https://doi. org/10.4103/0019-509X.200668. 6. Levendag P, Nijdam W, Noever I, Schmitz P, van de Pol M, Sipkema D, et al. Brachytherapy versus surgery in carcinoma of tonsillar fossa and/or soft palate: late adverse sequelae and performance status: can we bemore selective and obtain better tissue sparing? Int J Radiat Oncol Biol Phys 2004;59:713–24. https://doi. org/10.1016/j.ijrobp.2003.11.032. 7. Kelly K, Johnson-Obaseki S, Lumingu J, CorstenM. Oncologic, functional and surgical outcomes of primary Transoral Robotic Surgery for early squamous cell cancer of the oropharynx: a systematic review. Oral Oncol 2014;50:696–703. https://doi.org/10.1016/j.oraloncology.2014.04.005. 8. Pernot M, Hoffstetter S, Peiffert D, Aletti P, Lapeyre M, Marchal C, et al. Role of interstitial brachytherapy in oral and oropharyngeal carcinoma: reflection of a series of 1344 patients treated at the time of initial presentation. Otolaryngol-- Head Neck Surg Off J AmAcad Otolaryngol-Head Neck Surg 1996;115:519–26. https://doi.org/10.1016/S0194-59989670006-2. 9. Grabenbauer GG, Rödel C, Brunner T, Schulze-Mosgau S, Strnad V, Müller RG, et al. Interstitial brachytherapy with Ir-192 low-dose-rate in the treatment of primary and recurrent cancer of the oral cavity and oropharynx. Review of 318 patients treated between 1985 and 1997. Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al 2001;177:338–44. 10. Pericot J, Escribà JM, Valdés A, Biosca MJ, Monner A, Castellsagué X, et al. Survival evaluation of treatment modality in squamous cell carcinoma of the oral cavity and oropharynx. J Cranio-Maxillo-Fac Surg Off Publ Eur Assoc Cranio-Maxillo-Fac Surg 2000;28:49–55. https://doi.org/10.1054/jcms.1999.0091. 11. Bolner A, Mussari S, Fellin G, Pani G, Busana L, Caffo O, et al. The role of brachytherapy in the management of oropharyngeal carcinomas: the Trento experience. Tumouri 2002;88:137–41. 12. Strnad V. Treatment of oral cavity and oropharyngeal cancer. Indications, technical aspects, and results of interstitial brachytherapy. Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al 2004;180:710–7. https://doi.org/10.1007/ s00066-004-9196-x. 13. Chen J, Pappas L, Moeller JH, Rankin J, Sharma PK, Bentz BG, et al. Treatment of oropharyngeal squamous cell carcinoma with external beam radiation combined with interstitial brachytherapy. Head Neck 2007;29:362–9. https:// doi.org/10.1002/hed.20528. 14. Mazeron J-J, Noël G, Simon J-M. Head and neck brachytherapy. Semin Radiat Oncol 2002;12:95–108. https://doi.org/10.1053/srao.2002.28668. 15. Hu K, Harrison LB. Point: brachytherapy versus intensity-modulated radiation therapy in the management of base of tongue cancers. Brachytherapy 2005;4:1–4; discussion 7-8. https://doi.org/10.1016/j.brachy.2004.10.002. 16. Al-Mamgani A, Levendag PC, van Rooij P, Meeuwis CA, Sewnaik A, Teguh DN. Intensity-modulated radiotherapy followed by a brachytherapy boost for oropharyngeal cancer. Head Neck 2013;35:1689–97. https://doi.org/10.1002/ hed.23244. 17. Bhalavat RL, Vyas S, Jamema SV, Upreti R, Talole S, Medhi S. Quantitative estimation of doses to salivary glands from using brachytherapy in head